Adipose tissue-derived factors: impact on health and disease.
about
Wdnm1-like, a new adipokine with a role in MMP-2 activationEmerging role of bone morphogenetic proteins in adipogenesis and energy metabolismChildhood obesity, bone development, and cardiometabolic risk factorsAdipose tissue and adrenal glands: novel pathophysiological mechanisms and clinical applicationsAdipokines, metabolic syndrome and rheumatic diseasesRole of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseasesThe pathophysiology of abdominal adipose tissue depots in health and diseaseGQ-16, a Novel Peroxisome Proliferator-activated Receptor (PPAR ) Ligand, Promotes Insulin Sensitization without Weight GainPhysiological responses to food intake throughout the dayA branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistanceThe potential interplay of adipokines with toll-like receptors in the development of hepatocellular carcinomaCorrelation of circulating omentin-1 with bone mineral density in multiple sclerosis: the crosstalk between bone and adipose tissueMolecular, biochemical and functional characterizations of C1q/TNF family members: adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functionsFam57b (family with sequence similarity 57, member B), a novel peroxisome proliferator-activated receptor γ target gene that regulates adipogenesis through ceramide synthesisAntiobesity pharmacotherapy: new drugs and emerging targetsAdipocytokines in obesity and metabolic disease.Prenatal androgen exposure programs metabolic dysfunction in female mice.Cell density-dependent transcriptional activation of endocrine-related genes in human adipose tissue-derived stem cellsCXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance.Adiponectin activates adenosine monophosphate-activated protein kinase and decreases luteinizing hormone secretion in LbetaT2 gonadotropes.Characterization of human mesenchymal stem cell secretome at early steps of adipocyte and osteoblast differentiation.Fetuin-A induces cytokine expression and suppresses adiponectin production.Expression and regulation of transcript for the novel transmembrane protein Tmem182 in the adipocyte and muscle lineage.The UPS in diabetes and obesity.mRNA concentrations of MIF in subcutaneous abdominal adipose cells are associated with adipocyte size and insulin action.Dysregulation of adipose glutathione peroxidase 3 in obesity contributes to local and systemic oxidative stress.Quantitative secretome and glycome of primary human adipocytes during insulin resistance.Increased adiposity in the retinol saturase-knockout mouse.Adipocytokine orosomucoid integrates inflammatory and metabolic signals to preserve energy homeostasis by resolving immoderate inflammation.Specific metabolic biomarkers as risk and prognostic factors in colorectal cancer.Gender differences in insulin resistance, body composition, and energy balance.Involvement of inducible 6-phosphofructo-2-kinase in the anti-diabetic effect of peroxisome proliferator-activated receptor gamma activation in mice.Morphogenesis of the developing mammary gland: stage-dependent impact of adipocytes.Gender differences in rat plasma proteome in response to high-fat diet.The effective fraction isolated from Radix Astragali alleviates glucose intolerance, insulin resistance and hypertriglyceridemia in db/db diabetic mice through its anti-inflammatory activity.A novel non-agonist peroxisome proliferator-activated receptor γ (PPARγ) ligand UHC1 blocks PPARγ phosphorylation by cyclin-dependent kinase 5 (CDK5) and improves insulin sensitivityAnti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5.Relationships of circulating sex hormone-binding globulin with metabolic traits in humans.Thrap3 docks on phosphoserine 273 of PPARγ and controls diabetic gene programming.Cytosolic malic enzyme 1 (ME1) mediates high fat diet-induced adiposity, endocrine profile, and gastrointestinal tract proliferation-associated biomarkers in male mice.
P2860
Q24314696-6268FA9F-CACE-4F6E-A2E7-F15C0939B974Q24652412-CE5563F3-7713-486F-AC69-9D1870D0A8D2Q26853091-570C25D2-A8F5-4586-B4B1-54D277364474Q26860227-79643982-1E2F-4B9E-9F93-09EC26AAD0B4Q26865268-CC40FA2A-F2D0-4690-AB8A-D912CA165721Q27008359-7CBCD5D1-1246-4DA1-96BE-4F3F1686B5E5Q27012666-ED8607F0-2DA1-4B65-82C2-327EB2225200Q27679090-4BE5AF95-BF28-4F6D-9E4D-DDE5F00E6935Q28236687-5B60C6AC-1CFC-4B7C-9243-BC24CDE315C4Q28240815-00BDBBE9-718A-4073-9772-D4C6FFC5CEC3Q28392224-54A1B8D9-332F-461B-8604-B685F74F6C57Q28477087-3B10F9F3-D388-48C5-9F4C-AFE86AA77870Q28508387-67D8EAE9-913D-4D39-805A-C5E1E1470C51Q28589295-73CBB3C8-29E7-4606-ACB2-6BB05E42E9B0Q30354242-5B9779B2-56DB-4AF2-8260-CFB8B95715C2Q30357655-B466081E-FBBF-4F59-99D5-1472AF6DB063Q30421731-41A9014F-D009-48ED-A324-E7FCE9C4D1B5Q30431234-2C2045ED-A852-4393-8AB7-8DD17F235CD2Q30436563-2D2FA0F1-AC12-434B-ADFA-E3D61BC05A61Q30440168-0993AD5E-B625-407E-8974-9EF652B8B400Q33321325-38967C68-9F5E-41C7-A775-13FA43900523Q33323370-74F151EA-ED63-418C-92FE-E2E3F013D3F2Q33370657-A63196DB-7211-4880-B6EC-BDFC338BA2C2Q33384293-68549240-C2AA-41A8-B911-908125DB15FFQ33464150-4AE5B71C-49D2-4499-A92E-6210CC083859Q33642761-4E250F23-A945-4246-B600-A4289C58B716Q33749585-18892354-F23E-42C8-9369-3D72538B3E6CQ33752926-B9126424-04F5-4FC4-B3F1-0D841B56E53EQ33991014-D22A4030-868C-4642-80FA-63127B424BDDQ34008787-280B6A12-301E-482B-9729-D37A9471C1B7Q34013754-D1094455-4C30-4263-B19A-B2F140012BD3Q34025180-D2D65705-C1A3-4188-BABF-467A624169ECQ34050577-49AAA67E-12B2-496D-B3BD-A99B5A8AB3E0Q34106410-2B380ED4-6EE8-4EDD-8383-4DB8F4706BFFQ34114709-60B534E6-EE25-46E0-A9C0-F60D26F91DD1Q34249161-3FB70920-8876-4061-A641-2CACA7F9FF1DQ34330155-788E4DAC-D625-49BB-87E2-27A3129152BEQ34355301-8B41065C-E943-4DAA-A00F-7925A57C2F61Q34430709-2430E018-BCEC-4E79-A86A-BC7B15374033Q34441941-FE063981-66B5-455F-87E2-DC7E8BFC4988
P2860
Adipose tissue-derived factors: impact on health and disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Adipose tissue-derived factors: impact on health and disease.
@ast
Adipose tissue-derived factors: impact on health and disease.
@en
type
label
Adipose tissue-derived factors: impact on health and disease.
@ast
Adipose tissue-derived factors: impact on health and disease.
@en
prefLabel
Adipose tissue-derived factors: impact on health and disease.
@ast
Adipose tissue-derived factors: impact on health and disease.
@en
P356
P1433
P1476
Adipose tissue-derived factors: impact on health and disease.
@en
P2093
Maria E Trujillo
Philipp E Scherer
P304
P356
10.1210/ER.2006-0033
P577
2006-10-20T00:00:00Z